Lotus Apothecary

Project Alleviate




International Organization of Lotus Apothecary Project Alleviate is shown as follows:

Lotus Apothecary Project Alleviate
Lotus Apothecary Project Alleviate is a world headquarters located in NV, USA, with medical activities. The clinic for the initial biological treatments is provided. The company is currently applying for the clinical studies of phases I and II to Food and Drug Administration(FDA).

It is a declared objective of Lotus Apothecary Project Alleviate to keep and offer a first class GMP - performance in close coordination with the authorities, related to the State of the Art, and to offer this state to third parties, as well. Having generated data from phases I and II (proof of principle), LAPA or the ordering third party shall offer the project to interested pharmaceutical companies to develop the product further Jointly or, if the financial aspects are given to develop the drug on their own, till launching to the market.

Lotus Apothecary Project Alleviate
Lotus Apothecary Project Alleviate is a main institute and a laboratory for Research and Development (R&D) to prepare sterile drugs to Institute of Natural Health Care, Munich, Germany. Lotus Apothecary Project Alleviate, GmbH produces sterile pharmaceutical drugs and owns a world unique cell banks of our major products (i.e. Immune Modulator I & II). This institute provides the services and offers the third parties for the development of own projects like institutions from science and industry.

All the company's product developments are concentrated on natural and biological material to improve the immune system. The Lotus Apothecary Project Alleviate, GmbH has taken over the assets of the former CliPhar Medica GmbH & Co. KG including a suitable pilot facility to produce GMP complying sterile test samples for clinical studies - according to the statement of the authority.

The current facility was built in 2001 with a "hardware" investment of over 1.9 Million EURO and, considering the qualification work, validation, costs for staff, pre-clinical studies and consultancy, over 3.2 Million Euro have been invested. One big immaterial treasure Lotus Apothecary Project Alleviate has acquired is the high level of an international network of scientific competence centers. Academic, clinical research groups and pharmaceutical companies have already shown interest or become customers and/or partners of Lotus Apothecary Project Alleviate. Examples are: The Clinical Center of the Technical University of Munich, "Rfechts der Isar* and the chemical and medial institutes of the University of California, San Diego (UCSD), La Jolla, USA.







Lotus Apothecary Project Alleviate; Head office (NV), Administration office (NV)